Abstract
Butyrate is a microbial metabolite with pleiotropic effects. Schulthess et al. (2019) report that butyrate preconditioning of macrophages enhances their anti-bacterial preparedness by inducing anti-microbial proteins that restrict bacterial growth. This study augments understanding of how microbial metabolites shape host defense.
Original language | English |
---|---|
Pages (from-to) | 275-278 |
Number of pages | 4 |
Journal | Immunity |
Volume | 50 |
Issue number | 2 |
DOIs | |
State | Published - 19 Feb 2019 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Inc.
Funding
W.S.G. is a member of the SABs of Kintai Therapeutics, Evelo Biosciences, and Leap Therapeutics. She has consulted for Pfizer Consumer Health, Merck, Celgene, and BiomX in the past two years.
Funders | Funder number |
---|---|
BiomX | |
Evelo Biosciences | |
Kintai Therapeutics | |
Pfizer Consumer Health | |
Merck | |
Celgene |